GLP1 agonists set to become the best-selling drugs in 2024: GlobalData EP News Bureau Mar 15, 2024 Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
India is a key market for the company’s global plans EP News Bureau Aug 4, 2023 Vikrant Shrotriya, CVP & MD, Novo Nordisk India in an interaction with Express Pharma growth opportunities in pharma sector…
